By BioPharma Dive Reporting Team Published July 30, 2026 Alnylam Pharmaceuticals, the pioneer of RNA interference (RNAi)...
Main Facts: A Global Health Crisis Unfolds In the sweltering heat of May 2026, the World Health...
Published July 30, 2026 In the modern yoga studio, the narrative is often centered on the pursuit...
For an estimated 31 million Americans, the simple act of existing in one’s own skin is a...
LONDON, UK – In a landmark international study led by researchers at University College London (UCL), a...
Fifty-five years after the Controlled Substances Act of 1970 relegated psilocybin to Schedule I status—placing it alongside...
The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting served as a definitive turning point for...
A groundbreaking shift in how the medical community approaches neurodegenerative disease is currently underway, led by a...
Executive Summary: A Milestone in Structural Heart Intervention VDyne, a clinical-stage medical device company specializing in transformative...
Introduction: A Global Health Imperative Cancer remains one of humanity’s most formidable adversaries, exacting a devastating physical,...
